AETHLON MEDICAL INC
AEMD
AEMD: Aethlon Medical Inc is a medical technology company. It is focused on addressing unmet needs in health and biodefense. The company operates through two segments namely Aethlon for therapeutic applications, which represents its therapeutic business activities and ESI for diagnostic applications which signifies diagnostic business activities. It is focused on the development of Hemopurifier, a clinical-stage therapeutic device designed to combat cancer and to eliminate life-threatening viruses from the circulatory system. The company generates revenue from Aethlon segment.
moreShow AEMD Financials
Recent trades by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by AEMD's directors and management
Government lobbying spending instances
-
$30,000 Apr 17, 2012 Issue: Health Issues Defense
-
$30,000 Jul 21, 2011 Issue: Defense Health Issues
-
$20,000 Jul 21, 2011 Issue: Defense Health Issues
-
$20,000 Jul 21, 2011 Issue: Defense Health Issues
New patents grants
-
Patent Title: Method for removal of viruses from blood by lectin affinity hemodialysis Jul. 17, 2018
-
Patent Title: Extracorporeal removal of microvesicular particles Jul. 18, 2017
-
Patent Title: Extracorporeal removal of microvesicular particles Jun. 14, 2016
-
Patent Title: Extracorporeal removal of microvesicular particles Oct. 16, 2012
Federal grants, loans, and purchases
Followers on company's Twitter account
Number of mentions of AEMD in WallStreetBets Daily Discussion
Recent insights relating to AEMD
Recent picks made for AEMD on CNBC
ETFs with the largest estimated holdings in AEMD
Flights by private jets registered to AEMD